CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients

Por Lieberman, Linda A., Zeng, Wanyong, Singh, Carol, Wang, Wenting, Otipoby, Kevin L., Loh, Christine, Plavina, Tatiana, Gorelik, Leonid, Ransohoff, Richard M., Cahir-McFarland, Ellen
Publicado no Neurology (2016)

Carboxamide SIRT1 inhibitors block DBC1 binding via an acetylation-independent mechanism

Por Hubbard, Basil P, Loh, Christine, Gomes, Ana P, Li, Jun, Lu, Quinn, Doyle, Taylor LG, Disch, Jeremy S, Armour, Sean M, Ellis, James L, Vlasuk, George P, Sinclair, David A
Publicado em 2013

Pharmacological modulation of circadian rhythms by synthetic activators of the deacetylase SIRT1

Por Bellet, Marina M., Nakahata, Yasukazu, Boudjelal, Mohamed, Watts, Emma, Mossakowska, Danuta E., Edwards, Kenneth A., Cervantes, Marlene, Astarita, Giuseppe, Loh, Christine, Ellis, James L., Vlasuk, George P., Sassone-Corsi, Paolo
Publicado em 2013

Small molecule mediated inhibition of ROR γ‐dependent gene expression and autoimmune disease pathology in vivo

Por Banerjee, Daliya, Zhao, Linlin, Wu, Lan, Palanichamy, Arumugam, Ergun, Ayla, Peng, Liaomin, Quigley, Catherine, Hamann, Stefan, Dunstan, Robert, Cullen, Patrick, Allaire, Norm, Guertin, Kevin, Wang, Tao, Chao, Jianhua, Loh, Christine, Fontenot, Jason D.
Publicado no Immunology (2016)

SIRT1 Activators Suppress Inflammatory Responses through Promotion of p65 Deacetylation and Inhibition of NF-κB Activity

Por Yang, Hongying, Zhang, Wei, Pan, Heng, Feldser, Heidi G., Lainez, Elden, Miller, Christine, Leung, Stewart, Zhong, Zhong, Zhao, Huizhen, Sweitzer, Sharon, Considine, Thomas, Riera, Thomas, Suri, Vipin, White, Brian, Ellis, James L., Vlasuk, George P., Loh, Christine
Publicado em 2012